Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001861477-26-000003

EVP, Head of Research & Dev sold 3,435 shares at $21.47 ($73,749)

  • EVP, Head of Research & Dev acquired 6,715 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-03-24 Option exercise +6,715 6,715 D
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-03-25 Sale −3,435 $21.47 $73,749 3,280 D
Derivatives
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2026-03-24 Option exercise · Restricted Stock Units −6,715 20,146 D
Open-market sales · 3,435 sh · avg $21.47 · $73,749
Loading xslF345X06/form4-03262026_080306.xml…